Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
It was stated before that Omega's Scottish, Livingstone site is only one of the manufacturing partners for the RTC. If they are to sell 50m+ overseas, that's not surprising. The TV appearance didn't give any new information, but at least reassured that the wheels haven't quietly fallen off either the Mologic or RTC wagons without us being told yet (not uncommon among AIM firms), so it de-risked without giving ANY new concrete, disclosable, information. Some rampers misused the TV piece to imply mischievously that ODX would make all 50m tests, which isn't right and you don't look to any newspaper or TV piece for your facts - they "simplify" enormously. I guess that's why the speed check RNS said look, we're not making all 50 (Mr King won't have seen, perhaps, the lead-in piece, or had time to think about perception amplified by rampers). I guess the rise to 90p looked rather hasty and volatile. A rise to 60 - 70 at this stage would have been more decorous and usual; we are moving closer to the age of the antibody test, and the TV interview was subtly de-risking. I like that the government has poured cold water on the rival (american) antibody test Superdrug has been selling at £70 and instructed the lab by special order not to process the results; my colleague is going to have to get his money back from Superdrug. That is slightly positive for us because the American firm is a competitor. I bought more at 56p using borrowed money in the closing minutes today; I'll be happy to sell some of those in the next 2 days at 60p, and also hold some of my ODX for more rise if all goes well. I would have sold some above 70p, and all by 90p (obvious froth), but was chairing a meeting so couldn't glance.
They are all crowded onto the beach. I noticed laughter from inside my local pub, curtains now in place so you can't see in. Lock-ins. The real question is whether Cummings' actions affected the public’s adherence six weeks ago when we were at ‘the peak’. Clearly not because they didn't know; those who claim they saw him kept quiet until they could make more mischief/money, or the Guardian held it back for the same reason. People aren't going mad the last fortnight because of what some civil servant did (within the rules)
"apparently there is a rns due at some point today but lets see". Did you just make that up, I can see no source
Various people have told me that the existing covid tests are quite unpleasant, in that you have to put the stick right to your back of your mouth without getting saliva on it, and you gag, and then the same stick has to go so far up both nostrils and returned 5 times and it makes your eyes water and they really hated it (one said she would refuse to ever do another covid test) ...so a simple spit test that also gives an instant result and doesn't have to be sent off and be multiply-handled, with communication delays and getting lost and so on (like NYCT's old-tech first generation test), sounds great to me.
Great story in daily mail today .... https://mol.im/a/8336719... the firm in question is HEMO, the only US firm listed on the British stock exchange. Their humanised mice are being used for a lot of great research including covid.
Brooklyn, NY – A biotech start-up company supported by SUNY Downstate Medical Center’s Biotech Incubator (buffalo) has created a revolutionary new process for conditioning patients to receive bone marrow transplantation. In recognition of its technological..
Anyway, read the daily mail story, the above is from elsewhere in case anybody didn't know that was us. I haven't pasted the story out, but it's great
Is that 26 dollars the short run marginal cost with no contribution to overheads, or the long run marginal cost ? I like the number very much, just checking its basis as I know for some firms with a big corporate overhead, hopefully not this one, that can make a difference. Example, Ukog scrapes 300 barrels a day, and 6.85 dollars a barrel of that puny production is needed to pay its CEO's salary.
Yes, RTC is still there and separate from bluffing/dead-sounding mologic (?) : The UK Rapid Test Consortium, UK-RTC comprises Oxford University, BBI Solutions, Abingdon Health, CIGA Healthcare, Omega Diagnostics. Not been as rapid as Roche so far, but even if Roche stitches up much of EU and USA, there are other markets, and if RTC test is litmus-type, yet without the lack of accuracy that has so far dogged every single litmus-type test, then still a great way to do mass testing, if the bloated, statist, PHE bureaucracy can be persuaded to change direction a little. It's super-important to them that antibody tests are very accurate....
PHE is a huge bureaucracy and now they are going with Roche, it is problematic. Direction now set
unvrkw : Mologic are one of our partners, for the antibody test we'll make at Littleport near Ely. I read Liverpool hospital trust checked that out as accurate and it got CE mark. But ODX's scottish factory will also make the other UK consortium's covid antibody test. We do well if either test does well.
I like that massive final out of hours buy
"There are plenty of large IT firms that can build a blockchain database. Why would any government partner with a micro cap entity that is almost technically insolvent for such a critical piece of software?" - convincingly put
I see someone bought over £300k at 5:29pm today, apparently BST. How's that possible ? Normally on my stocks I see a few trades go through from 4:30 to as late as 4:40. I've googled it before, there is a serious paucity of info on this matter on line, but no broker I have ever used has allowed me to trade then, so it seems like some kind of closed shop. https://www.tradinghours.com/exchanges/lse/trading-hours says "Closing Auction from 4:30 PM to 4:35 PM
Post Close from 4:40 PM to 5:15 PM
Extended Hours Trading allows investors to act quickly on information that comes out after markets closed. In the past, only large institutional investors could participate in Extended Hours Trading. Due to the emergence of electronic trading platforms, individual investors are now able to trade during extended hours as well. Depending upon your broker, you can usually choose to execute trades during pre- or after-hours if you want". I don't think that's true ??? And really, so late as 5:29 is really weird on a UK-listed stock ? I never saw that before. Is it dual-listed on an EU exchange on the continent, or some scam like that ??? https://www.londonstockexchange.com/exchange/prices-and-markets/stocks/summary/company-summary/GB00B15FWH70GBGBXSTMM.html also shows the large 5:29 buy.
My hunch (and unlike other posters I won't pretend that I have undertaken undisclosed business modelling to prove it !) is that the price of stocks like Novacyt are way above what they should be, just because tonnes of private investors are sitting at home on furlough or whatever, looking for what's fashionable and every broker runs email mailouts and the like of covid stocks to invest in. They are wary and look for one that's frothing already and pile in. Hemo hasn't been mentioned on many of those lists so it hasn't had the froth. It was worth 2 to 2.5p across January and it's 6.8 or so today. Whereas NYCT was 12p across Jan average and is now 431. OK NYCT has the transient benefit of providing the NHS with some of its covid antigen tests, until better instant ones that don't need transport, multiple handling and a special £6k machine, come in - that multiple competitors are working on. Stock like NYCT seems massively over-valued for the long term and one day the holders of it will be left stranded or realise a big loss (albeit if they had it since January they'll be fine). CTEA and TERN the same, it's evident they didn't get the NHS movement tracker contract and EU countries are using Apple's and Google's, so they'll collapse a lot more as the penny drops. Hemo has some genuine IPR that could be useful for cancer and for modelling a range of human diseases, to fall back on. To me it's a far more solid punt than the other covid-related stocks, in terms of limited downside, generous upside. Actually I've almost convinced myself to add it to my long term hold list, alongside my beloved Eden, and just ride any ups and downs along the way.
I do wish people wouldn't claim buys and sells are being misrecorded. Maybe sometimes they are, but I often think the poster is far from disinterested, so I pay no attention and it's a waste of bandwidth. I don't actually care if one or two, or indeed three or four, are misrecorded. If you've got level 2 you can see where the orders are above/below current SP and if there are some trades that might be misrecorded when spread is small, or because someone got a generous traded price at mid price, who cares; sometimes the misrecord will go one way, sometimes another.
I'm out of all but one Covid stocks now, as there is too much money on them, they have become too frothy. So glad I sold CTEA and ODX at (small) profit a few days back. Most of them, you can easily get stranded when they fall out of fashion, as they have so little except the covid-hope to sustain their price. But .... look at the other RNSs on hemo earlier this year. A colleague was cured of his blood cancer Myloma (normally almost incurable) using bone marrow stem cells (they first killed or removed his bone marrow, I think, then he grew new marrow ? I didn't hear it first hand from the doc, and any intermediary tends to blur the science) - and some of Hemo's work is right in that space. They wholly own the subsidiary firm that makes human-like cells in mice, all patented, that I hope can help a lot with research on all kinds of human conditions - yes, maybe including Covid - and, separately, the bone marrow work by the founder of Hemo is globally patented too (by hemo) and recently licensed in USA and EU. I don't understand it in detail (I don't think most posters on most stocks' BB's understand the science or business/operational details of their stock - most posters seem to be pretending to ! Otherwise there's one heck of a lot of world experts out there on oil extraction, gold and lithium mining, etc...), but to me it sounds promising, and this one hasn't gone up as much as the frothier and more fashionable (earlier on) Covid stocks did. If it hit about 8.2 (unless what I judge at least a semi-transformative or very good RNS comes out, in which case I'll hang on for the longer term) I'd probably consider it frothing, depending on how fast and in what manner it got there, and might then be out for a while. (it is not mandatory to be a long term holder in order to have a view on a stock [or even to hold it at all !] - nor to pretend to be a long term holder "for years to come at least, only ever buying never selling" in your posts when, for one given stock, maybe you're not - I suspect a lot of dishonesty in some others' posts on this point, not on this stock I mean but on stock chat rooms in general. Hardly anyone admits to selling and if anyone does they're flamed as a traitor - but people who sell are just as interested in a stock just as much as those who buy). If I can sell something else, I might even punt more on this - depends on other stocks' prices.